American Society of Hematology, Blood, 11(126), p. 1379-1389, 2015
DOI: 10.1182/blood-2015-01-622811
Full text: Download
Key Points Polyphosphate-activated coagulation factor XII drives prostate cancer-associated venous thrombosis. Targeting the polyphosphate/factor XII pathway reduces procoagulant activity in prostate cancer patient plasma and may permit safe anticoagulation.